First-of-its-Kind stem cell trial for young hearts
NCT ID NCT06464588
Summary
This early-stage study is testing whether infusions of donor stem cells are safe for young adults and children with dilated cardiomyopathy, a condition where the heart muscle is weakened and enlarged. Researchers will give participants three monthly intravenous infusions and monitor them closely for side effects over 14 months. The study will also check if the treatment might help improve heart function and quality of life.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DILATED CARDIOMYOPATHY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Egleston Children's Hospital
RECRUITINGAtlanta, Georgia, 30322, United States
Contact
Contact
-
Emory Children's Center
RECRUITINGAtlanta, Georgia, 30322, United States
Contact
Contact
-
Emory University Hospital
RECRUITINGAtlanta, Georgia, 30322, United States
Contact
Contact
-
Hughes Spalding Children's Hospital
RECRUITINGAtlanta, Georgia, 30303, United States
Contact
Contact
-
Scottish Rite Children's Hospital
RECRUITINGAtlanta, Georgia, 30342, United States
Contact
Contact
Conditions
Explore the condition pages connected to this study.